Nino Guy Cassuto

Dr. Nino Guy Cassuto

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2009 in Fertility and Sterility
Verified
Journal Article
Closed access
NCNino Guy Cassuto
Nino Guy Cassuto
DBDominique Bouret
Dominique Bouret
JPJean Michel Plouchart
Jean Michel Plouchart
SJSonia Jellad
Sonia Jellad
PVPierre Vanderzwalmen
Pierre Vanderzwalmen
YBYona Barak
Yona Barak

1 February 2012 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
NCNino Guy Cassuto
Nino Guy Cassuto
AHAndré Hazout
André Hazout
IHIbrahim Hammoud
Ibrahim Hammoud
RBRichard Balet
Richard Balet
DBDominique Bouret
Dominique Bouret
CYChadi Yazbeck
Chadi Yazbeck

1 January 2014 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
NCNino Guy Cassuto
Nino Guy Cassuto
AHAndré Hazout
André Hazout
DBDominique Bouret
Dominique Bouret
RBRichard Balet
Richard Balet
LLLionel Larue
Lionel Larue
GVGéraldine Viot
Géraldine Viot

11 April 2016 in BioMed Research International
Verified
Journal Article
Open access
PDF file
NCNino Guy Cassuto
Nino Guy Cassuto
DMDebbie Montjean
Debbie Montjean
JSJean-Pierre Siffroi
Jean-Pierre Siffroi
DBDominique Bouret
Dominique Bouret
FMFlora Marzouk
Flora Marzouk
MBMoncef Benkhalifa
Moncef Benkhalifa
Objective. To analyze DNA methylation levels between two groups of spermatozoa taken from the same sample, following morphological selection by high magnification (HM) at 6100x microscopy. A prospective study was conducted and studied 876 spermatozoa from 10 randomly selected men. Sperm morphology was characterized at HM according to criteria previously established. High-scoring Score 6 and low-scoring Score 0 sperm were selected. Sperm DNA methylation level was assessed using an immunoassay method targeting 5-methylcytosine residues by fluorescence microscopy with imaging analysis system to detect DNA methylation in single spermatozoon.Results. In total, 448 S6 spermatozoa and 428 S0 spermatozoa were analyzed. A strong relationship was found between sperm DNA methylation levels and sperm morphology observed at HM. Sperm DNA methylation level in the S6 group was significantly lower compared with that in the S0 group (p<10-6), OR = 2.4; andp<0.001, as determined using the Wilcoxon test.Conclusion. Differences in DNA methylation levels are associated with sperm morphology variations as observed at HM, which allows spermatozoa with abnormal levels to be discarded and ultimately decrease birth defects, malformations, and epigenetic diseases that may be transmitted from sperm to offspring in ICSI.

1 October 2017 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
ARAlexandre Rouen
Alexandre Rouen
LCLéa Carlier
Léa Carlier
SHSolveig Heide
Solveig Heide
MEMatthieu Egloff
Matthieu Egloff
PMPauline Marzin
Pauline Marzin
JSJean-Pierre Siffroi
Jean-Pierre Siffroi

Verified
Journal Article
Open access
PDF file
NLNathalie Lédée
Nathalie Lédée
MPMarie Petitbarat
Marie Petitbarat
LPLaura Prat-Ellenberg
Laura Prat-Ellenberg
GDGéraldine Dray
Géraldine Dray
VVVirginie Vaucoret
Virginie Vaucoret
MRMona Rahmati
Mona Rahmati
Assisted reproduction techniques have improved considerably in recent decades, but despite these advances, success rates remain relatively low. Endometrial immune profiling involves the analysis of cytokine biomarkers in the endometrium during the mid-luteal phase. This profiling aims to provide insights into the immune environment of the uterus. The aim is to identify immune disturbances and thus guide the development of personalized therapeutic approaches. The first part of the review looks back at the emergence of innovative concepts, highlighting the specificity of the human uterine environment at the time of implantation. Based on this new knowledge, biomarkers have been selected for endometrial immune profiling. The second part details the results of clinical studies conducted over the last ten years. These clinical results suggest that this approach can increase the rate of live births in patients suffering from repeated implantation failures or repeated pregnancy loss. Uterine immune profiling represents a clinical innovation that can significantly improve the performance of medically assisted reproduction treatments through personalized strategies tailored to the local immune profile. Innovation in personalized medicine for assisted reproduction is crucial to improving the success rates of fertility treatments, while reducing the risks and costs associated with ineffective or unnecessary interventions.